Skip to main content

Table 2 Description of outcome measures, effectiveness, adverse events, and completion rates

From: Distant mood monitoring for depressive and bipolar disorders: a systematic review

Authors

Primary Outcome Measures (Comparison and Outcome)

Feasibility and Effectiveness (Outcome)

Depression scale/instrument

Mania

Frequency

Adverse events reported

Completion Rate

Effective

Faurholt-Jepsen, Vinberg et al., 2015c

HAMD-17

YMRS

Monthly for 6 months

Trained nurse contacted participant if deterioration in symptoms detected.

Results NS

Intervention: 33/39 = 82.62%

Control: 34/39 = 87.18%

No significant improvement in HAMD-17 or YMRS scores.

Lauritsen et al., 2017 [36]

HAMD-17; MINI; MDI

NA

Baseline; at 4 weeks

5 participants were readmitted to an inpatient ward due to worsening depression (self-monitoring continued)

General: 34/45 = 76%

59% of participants believed that the system could detect a relapse, 50% believed that the system could influence the course of their illness, and 50% felt that the system had covered their needs for self-monitoring.

No significant improvement in self-assessed mood scores. Significant improvement in HAMD-17 and MDI scores.

Martinez et al., 2018

BDI

NA

Baseline; at 12 weeks

NS

Intervention: 65/65 = 100%

EUC control: 73/78 = 83.49%

Participants rated the intervention as 6/7 (88.57%) in terms of both usefulness and comfort. Clinicians rated the intervention for usefulness for clinical work (90%), usefulness for patients (92.86%), and comfort (85.71%).

No significant differences were observed across arms at 12-week follow-up in terms of depressive symptomology. However, regression analysis indicated (i) for each extra point in baseline BDI scores, a reduction of 0.5 points in BDI scores at 12 weeks; and (ii) for each additional point in satisfaction with the psychological care received, a reduction of 4.3 points in BDI scores at 12 weeks.

Piette et al., 2013 [37]

PHQ-9

NA

Week 1–6: Weekly with option to reduce to monthly if depression scores were mild enough. Could revert to weekly at any time.

Alerts generated for suicidal ideation, poor medication adherence, and increased depressive symptom severity.

Alerts were triggered at a rate of 4.9 per 100 person-weeks of participation.

11% attrition in first 6 months; 68% assessment completion

NS

Ross et al., 2008 [38]

PHQ; MINI

NA

Baseline; at 6 months

Participants (37.7%) referred to the behavioural health specialist.

Intervention: 96/130 = 73.85%

Control: 72/93 = 77.42%

Intervention group had less (not significantly) depression symptoms and diagnoses at 6-months follow-up than control group.

Van der Watt, Roos et al., 2018

QIDS

ASRM

Weekly for 26 weeks

Participants reported negative (10.8%) and apprehensive (16.2%) experience of baseline assessment.

Interviews conducted regarding effectiveness: 60.7%

Majority of participants interviewed (86.5%) reported that they found the mood monitoring helpful.

Van der Watt, Suryapranata et al., 2018

QIDS

ASRM

Weekly for 26 weeks

NS

45.9%

Significant improvement in QIDS scores.

No significant difference in ASRM scores.

Yeung et al., 2012a‑ [39]

PHQ-9; PGI-S

NA

Monthly

Physicians were sent reports on participants’ PHQ scores. 273 PHQ-9 responses endorsing thoughts of self-harm were reported to physicians.

Intervention: 364/503 = 72.37%

Control: 278/412 = 67.48%

45% achieved remission by the end of the study, with the intervention group being significantly more likely to achieve remission.

53.9% fulfilled the response criterion (50% + reduction in PHQ-9 scores), with the intervention group being significantly more likely to achieve response.

Zulueta et al., 2018 [34]

HAMD-17

YMRS

Weekly

NS

Participation varied in terms of the number of weeks that had any keyboard activity, with an average of 4.69 (3.05) weeks. Only 9 participants (9/16 = 56.25%) complete at least 4 weeks.

Decrease in HAMD-17 scores: Week 1 = 11.90 (3.17); Week 8 = 11.11 (5.49). Significance not reported.

Decrease in YMRS scores: Week 1 = 7.56 (5.00); Week 8 = 6.67 (4.03). Significance not indicated.

  1. ASRM Altman Self-Rating Mania Scale, BDI Beck Depression Inventory, HAMD-17 Hamilton Depression rating scale, MDI Major Depression Inventory, MINI Mini-International Neuropsychiatric Interview, NA Not Applicable, NS Not Specified, PGI-S Patient Global Impression Severity, PHQ Personal Health Questionnaire, QIDS Quick Inventory of Depressive Symptomatology, YMRS Young Mania Rating Scale
  2. aDemographic data only presented for participants who completed the study
  3. bDemographic data only presented for participants who completed the study
  4. cDemographic data only presented for participants who completed the study